Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Clene Inc. Common Stock (CLNN)

Pharmaceutical Preparations

https://www.clene.com

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).

6550 SOUTH MILLROCK DRIVE, SUITE G50
SALT LAKE CITY, UT

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/31/2020

Market Cap

32,997,357

Shares Outstanding

128,419,999

Weighted SO

128,415,605

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

MNOV --.--%

MNOV --.--%

ELYM --.--%

ELYM --.--%

MOLN --.--%

CSBR --.--%

CYT --.--%

Beta

0.4590

Last Div

0.0000

Range

3.82-15.6

Chg

0.2200

Avg Vol

110484

Mkt Cap

32997357

Exch

NASDAQ

Country

US

Phone

801 676 9695

DCF Diff

5.5745

DCF

-0.5445

Div Yield

0.0000

P/S

74.6547

EV Multiple

-1.2611

P/FV

-1299.9297

Div Yield %

0.0000

P/E

-21.5118

PEG

-0.8299

Payout

-0.0066

Current Ratio

0.9943

Quick Ratio

0.9930

Cash Ratio

0.7725

DSO

1004.9887

DIO

10.0784

Op Cycle

1015.0670

DPO

290.3657

CCC

724.7014

Gross Margin

-2.0317

Op Margin

-81.6629

Pretax Margin

-68.9050

Net Margin

-68.9050

Eff Tax Rate

-0.3948

ROA

-0.7552

ROE

-3.1597

ROCE

-2.9439

NI/EBT

1.0000

EBT/EBIT

0.8438

EBIT/Rev

-81.6629

Debt Ratio

0.6965

D/E

-55.7321

LT Debt/Cap

1.0774

Total Debt/Cap

1.0183

Int Coverage

1388.2692

CF/Debt

-0.9760

Equity Multi

-80.0198

Rec Turnover

0.3632

Pay Turnover

1.2570

Inv Turnover

36.2162

FA Turnover

0.0358

Asset Turnover

0.0110

OCF/Share

-0.2134

FCF/Share

-0.2142

Cash/Share

0.1688

OCF/Sales

-62.0249

FCF/OCF

1.0038

CF Coverage

-0.9760

ST Coverage

-1.3008

CapEx Coverage

-262.4771

Div&CapEx Cov

-90.0484

P/BV

-1299.9297

P/B

-1299.9297

P/S

74.6547

P/E

-21.5118

P/FCF

-1.1991

P/OCF

-23.8980

P/CF

-23.8980

PEG

-0.8299

P/S

74.6547

EV Multiple

-1.2611

P/FV

-1299.9297

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 14, 08:36 Clene Announces Peer-Reviewed Publication Describing CNM-Au8 Brain Target Engagement In Neurodegenerative Diseases

Revenue Product Segmentation